Gulsen Demir-Akman

Istanbul, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Real-world effectiveness and safety of eculizumab in AQP4-IgG-positive neuromyelitis optica spectrum disorder.

Real-world effectiveness and safety of eculizumab in AQP4-IgG-positive neuromyelitis optica spectrum disorder.

Journal: Journal of neurology

Published: November 04, 2025

Corrigendum to "Severe disease reactivation in seropositive neuromyelitis optica spectrum disorders patients after stopping eculizumab treatment" [Multiple Sclerosis and Related Disorders, Volume 79, November 2023, https://doi.org/10.1016/j.msard.2023.104949].

Corrigendum to "Severe disease reactivation in seropositive neuromyelitis optica spectrum disorders patients after stopping eculizumab treatment" [Multiple Sclerosis and Related Disorders, Volume 79, November 2023, https://doi.org/10.1016/j.msard.2023.104949].

Journal: Multiple sclerosis and related disorders

Published: October 18, 2024

Severe disease reactivation in seropositive neuromyelitis optica spectrum disorders patients after stopping eculizumab treatment.

Severe disease reactivation in seropositive neuromyelitis optica spectrum disorders patients after stopping eculizumab treatment.

Journal: Multiple sclerosis and related disorders

Published: May 15, 2023

Treatment of MOG antibody associated disorders: results of an international survey.

Treatment of MOG antibody associated disorders: results of an international survey.

Journal: Journal of neurology

Published: May 12, 2020

Laboratory and clinical correlates of brain atrophy in Neuro-Behçet's disease.

Laboratory and clinical correlates of brain atrophy in Neuro-Behçet's disease.

Journal: Journal of the neurological sciences

Published: December 13, 2019

Characteristics of optic neuropathy in Behçet disease.

Characteristics of optic neuropathy in Behçet disease.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: December 18, 2017

Pseudotumor cerebri syndrome without cerebral venous sinus thrombosis in Behçet's disease.

Pseudotumor cerebri syndrome without cerebral venous sinus thrombosis in Behçet's disease.

Journal: Journal of the neurological sciences

Published: September 24, 2017

The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature.

The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature.

Journal: Journal of neurology

Published: November 03, 2016

Behçet's Disease and Nervous System Involvement.

Behçet's Disease and Nervous System Involvement.

Journal: Current treatment options in neurology

Published: March 24, 2016

Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes.

Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes.

Journal: Journal of neurology

Published: September 03, 2015

Behçet's disease patients with multiple sclerosis-like features: discriminative value of Barkhof criteria.

Behçet's disease patients with multiple sclerosis-like features: discriminative value of Barkhof criteria.

Journal: Clinical and experimental rheumatology

Published: October 27, 2014

Predictive value of early serum cytokine changes on long-term interferon beta-1a efficacy in multiple sclerosis.

Predictive value of early serum cytokine changes on long-term interferon beta-1a efficacy in multiple sclerosis.

Journal: The International journal of neuroscience

Published: July 16, 2014

Showing 1-12 of 38

Last Updated: 09/26/2026